Neurocentrx Pharma
PrivateLast Round
Seed
Sep 23, 2025
Total Funding Raised
$5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neurocentrx Pharma is a biopharmaceutical company developing oral ketamine formulations designed to treat patients with mood disorders and other neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurocentrx Pharma Comparables
Compare Neurocentrx Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tasman Therapeutics | 88% | |
| HMNC Brain Health | 85% | |
| AtaiBeckley Inc. | 79% | |
Neurocentrx Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 23, 2025 | ||||
| Series A | Sep 23, 2025 | ||||
| VC Round | May 12, 2022 | ||||
| Angel | Mar 20, 2014 |
Neurocentrx Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| o2h ventures | VC Round |
| Equity Gap | VC Round, Angel |
| Meltwind Advisory | VC Round |
| Old College Capital | VC Round |
| Neo Kuma Ventures | VC Round |
| Scottish Investment Bank (Scottish Enterprise) | VC Round |
| Wellcome Trust | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 163% MoM, reaching 1.5K.
Neurocentrx Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neurocentrx Pharma's valuation, stock price, and market status.